Related Experiment Videos
[Trials with gabapentin monotherapy in patients with complex partial or secondary generalized seizures]
1Parke-Davis, Abteilung für Pharmazeutische Forschung, Warner-Lambert, Ann Arbor, Michigan, USA.
Praxis
|February 12, 1998
Abstract:
Neurontin (Gabapentin) is indicated as an add-on treatment of partial epileptic seizures. Clinical studies demonstrating the efficacy of Neurontin as monotherapy are currently on going. This article describes the design of 2 clinical trials of Gabapentin as monotherapy for epileptic seizures.